Asthma Trial, Recruiting NCT05496582 Sponsor: Shanghai University of Traditional Chinese Medicine Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05496582
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 14 and 75 years old, either male or female
  • People who have been formally diagnosed with bronchial asthma
  • People whose asthma diagnosis meets the Global Initiative for Asthma (GINA) guidelines, including a breathing test showing the airways respond to bronchodilator medication (confirm with trial site)
  • Healthy volunteers who do not have respiratory symptoms such as cough, wheezing, chest tightness, or shortness of breath
  • People who are willing to sign a consent form agreeing to all procedures in the trial

Who may not be able to join:

  • People who have chronic obstructive pulmonary disease (COPD) or other airway conditions
  • People who have other serious health conditions, such as high blood pressure, cancer, an overactive thyroid, bronchiectasis, or heart failure, or any condition that could make participation unsafe
  • People who are pregnant or breastfeeding
  • People who are not willing to take part
  • People with a history of psychiatric or neurological conditions that affect their ability to function normally
  • People whom the research team considers unsuitable for the study for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lei-Miao Yin, MD, Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Phone: 13774384237

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai University of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Difference in gene expression of transgelin-2, metallothionein-2 and ezrin between controls and asthmatic patients; Association of transgelin-2, metallothionein-2 and ezrin with asthma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov